Context Dependent Regulation of Human Phosphoenolpyruvate Carboxykinase Isoforms by DNA Promoter Methylation and RNA Stability

Abstract

Cytoplasmic and mitochondrial isoforms of phosphoenolpyruvate carboxykinase (PEPCK-C and PEPCK-M) regulate hepatic gluconeogenesis to control systemic glucose homeostasis. Transcriptional and post-transcriptional mechanisms may govern synthesis, maintenance and cooperative function of compartmentalized PEPCK enzymes. In a comparative analysis, we show that tumor cells consistently transcribe and translate higher levels of enzymatically active PEPCK-C than PEPCK-M and both the isoforms were present at lower levels in normal fibroblasts. Unlike in PEPCK-M, absence of glucose reduced the PEPCK-C mRNA and protein levels only in HepG2 cells. Interestingly, isoflavone genistein significantly increased PEPCK-C mRNA and protein levels in normal fibroblasts indicating cell type specific control mechanisms. Genistein also significantly affected RNA stability of PEPCK-C but not PEPCK-M in HepG2 cells. This was due to the conserved and functional mRNA destabilizing AU rich sequences at the 3'-UTR region of PEPCK-C gene and was confirmed by luciferase reporter assays suggesting that glucose deprivation and genistein targets these sequences for mRNA degradation in HepG2 cells but not in fibroblasts. Analysis of promoter methylation by luciferase reporter assays and bisulfite DNA sequencing suggested that PEPCK-C but not PEPCK-M promoter was activated by 5-aza-2-deoxycytidine by inducing cytosine demethylation at the specific CpG dinucleotides of 5'-UTR region. Taken together, our data suggests stable PEPCK-M activity and identifies intricate relationship between (1) mRNA stability and (2) promoter DNA methylation as two mechanisms of gene expression that distinguishes PEPCK-C and PEPCK-M enzyme activities in a context and cell type dependent manner during gluconeogenesis. J. Cell. Biochem. 117: 2506-2520, 2016. © 2016 Wiley Periodicals, Inc.

Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors

“…However, Seenappa et al reported that PEPCK-C protein expression was markedly reduced in the cancer cell line HepG2 cells but reduced at a lower extent in fibroblasts under culture conditions lacking glucose. However, PEPCK-M protein expression was slightly elevated in HepG2 cells and not altered in fibroblasts under the same conditions [ 25 ]. In summary, the regulation of PEPCK-C and PEPCK-M in response to glucose deprivation is different among different cancer types and not the same as that of normal cells.…”

SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism

“…Phosphoenolpyruvate carboxykinase (PEPCK) is the classic downstream target of SIRT2, as well as the rate-limiting enzyme of gluconeogenesis, and catalyzes the conversion of oxaloacetate (OAA) into phosphoenolpyruvate (PEP). PEPCK is found in two forms: cytosolic (PEPCK1) and mitochondrial (PEPCK2) [11] . A recent study confirmed that PEPCK1 could contribute to cancer anabolic metabolism by increasing glucose and glutamine utilization [12] .…”

Effects of kinsenoside, a potential immunosuppressive drug for autoimmune hepatitis, on dendritic cells/CD8+T cells communication in mice

“…E). Given that mitochondria are central to the metabolism of glucose and lipid, we speculate that suppression of fuel metabolism and energy production might contribute importantly to the mechanism of immune cell suppression by KD.…”